tetano
Editor, Senior Moderator
Int J Dermatol
. 2021 Sep 22.
doi: 10.1111/ijd.15889. Online ahead of print.
COVID-19-related oral mucosa lesions among confirmed SARS-CoV-2 patients: a systematic review
Gizem S Erbaş[SUP] 1 [/SUP], Aysenur Botsali[SUP] 2 [/SUP], Nihan Erden[SUP] 3 [/SUP], Canan Arı[SUP] 4 [/SUP], Banu Taşkın[SUP] 5 [/SUP], Sibel Alper[SUP] 5 [/SUP], Secil Vural[SUP] 5 [/SUP]
Affiliations
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the virus responsible for coronavirus disease 2019 (COVID-19), which manifests as a flu-like respiratory infection affecting multiple organ systems, including the gastrointestinal system, central nervous system, cardiovascular system, skin, and mucosa. In this review, we investigated the literature on specific manifestations of COVID-19 in the oral mucosa. An online literature search in PubMed, Scopus, Google Scholar, and Medline was conducted to retrieve relevant studies on confirmed COVID-19 patients with oral mucosa findings published between December 31, 2019, and April 07, 2021. After an independent review by two authors, 39 articles considering 59 laboratory-confirmed cases of SARS-CoV-2 infection were included in the final analysis. The most common finding, reported in 29 patients (43.9%), was Kawasaki-like syndrome. In addition, oral ulcers including aphthous, hemorrhagic, and necrotic ulcers were reported in 24 patients (36.3%). Other lesions reported included pustules, macules, bullae, maculopapular enanthema, and erythema multiforme-like lesions. Concomitant skin lesions were present in 60.6% of patients. Fever was reported in 86.2% of patients. Forty-eight patients (76.1%) were hospitalized. Loss of taste and smell was present in 30.8% of the patients. A comprehensive understanding of the dermatologic manifestations of COVID-19 can improve and facilitate patient management and referrals.
. 2021 Sep 22.
doi: 10.1111/ijd.15889. Online ahead of print.
COVID-19-related oral mucosa lesions among confirmed SARS-CoV-2 patients: a systematic review
Gizem S Erbaş[SUP] 1 [/SUP], Aysenur Botsali[SUP] 2 [/SUP], Nihan Erden[SUP] 3 [/SUP], Canan Arı[SUP] 4 [/SUP], Banu Taşkın[SUP] 5 [/SUP], Sibel Alper[SUP] 5 [/SUP], Secil Vural[SUP] 5 [/SUP]
Affiliations
- PMID: 34549816
- DOI: 10.1111/ijd.15889
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the virus responsible for coronavirus disease 2019 (COVID-19), which manifests as a flu-like respiratory infection affecting multiple organ systems, including the gastrointestinal system, central nervous system, cardiovascular system, skin, and mucosa. In this review, we investigated the literature on specific manifestations of COVID-19 in the oral mucosa. An online literature search in PubMed, Scopus, Google Scholar, and Medline was conducted to retrieve relevant studies on confirmed COVID-19 patients with oral mucosa findings published between December 31, 2019, and April 07, 2021. After an independent review by two authors, 39 articles considering 59 laboratory-confirmed cases of SARS-CoV-2 infection were included in the final analysis. The most common finding, reported in 29 patients (43.9%), was Kawasaki-like syndrome. In addition, oral ulcers including aphthous, hemorrhagic, and necrotic ulcers were reported in 24 patients (36.3%). Other lesions reported included pustules, macules, bullae, maculopapular enanthema, and erythema multiforme-like lesions. Concomitant skin lesions were present in 60.6% of patients. Fever was reported in 86.2% of patients. Forty-eight patients (76.1%) were hospitalized. Loss of taste and smell was present in 30.8% of the patients. A comprehensive understanding of the dermatologic manifestations of COVID-19 can improve and facilitate patient management and referrals.